About this episode

This episode discusses the latest compounding news and state-level legislation affecting pharmacy compounding advocacy.

This episode we look at some of the latest compounding news, and then we’ve got a deep dive into state-level legislation with the Leading Ladies of Pharmacy Compounding Advocacy.What bills are being introduced? What do they really mean when you read the detail? How will they affect state policies, and what could come next? And, of course, how are APC and compounding pharmacies fighting back against the bad bills that put patients at risk?If you’re a compounder, if you have patients who use compounded medications, or if you’re a patient yourself, you’ll want to hear this.Links from the podcast:The FDA statement on excluding GLP-1s from bulk compounding: https://fllw.me/491oGl3FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C (part 1), https://fllw.me/4nxd13G (part 2)Is It Legit? to find a state-licensed compounding pharmacy: https://a4pc.org/isitlegitJoin APC! https://a4pc.org/join

More episodes of Pharmacy Podcast Network

• Asembia's Specialty Pharmacy Summit Rewind 2026 | 6/6 · June 5, 2026 · 52 min
• Birth Rights, Medical Bills & Legal Advocacy with Andi Orwoll, Esq. | MaternalRx · June 4, 2026 · 38 min
• Why the Pharmacy Supply Chain Breaks — and What Leaders Must Do About It | Executive Dose · June 3, 2026 · 39 min
• Transparency, Auditing, and the PBM Shell Game | PBM Reform Podcast · June 2, 2026 · 48 min
• YARAL Pharma’s Bold Approach to the U.S. Generics Market | Yaral Pharma · June 1, 2026 · 35 min

Explore listener stats, chart rankings, contacts and more on the Pharmacy Podcast Network podcast page.